Global oral drug delivery market is expected to grow at a CAGR of around 7% during the forecast period. The global oral drug delivery market is driven by rising prevalence of chronic diseases across the globe. Moreover, growing research and development investment by various pharmaceutical companies worldwide is positively impacting the growth of market during the forecast period. Also, oral drug delivery is the most favoured mode of administration for essential drugs in various therapeutic areas which is further expected to bolster the growth of market over the next few years.

The global oral drug delivery market is segmented based on formulation, type, therapy area, end user, company, and region. Based on formulation, the market can be categorized into tablets, capsules, drops, liquid or syrup. Out of which, the tablets segment dominated the market in terms of largest market share until 2020 and is expected to maintain its leading position in the market during the forecast period as well. This can be ascribed to wide range of advantages associated with this formulation, including convenience and ease of use, high stability, longer shelf life, among others.  In addition to this, capsules are anticipated to register high growth in the coming years which can be attributed to odourless, tasteless, easy to swallow nature. Also, capsule provides faster relief from symptoms when compared to tablets, which is further contributing the segmental growth through 2026.

The major players operating in the oral drug delivery market are Novartis AG, Biocon Ltd., NovoNordisk A/S, F.Hoffmann-La Roche Ltd., Bayer AG, Emishphere Technologies Inc., Enteris Biopharma Inc., Merrion Pharmaceuticals Plc., Amgen Inc., Pfizer Inc, and others. Major companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, research agreements and new product launches in order to expand their geographic reach and to increase their customer bases.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022–2026

Objective of the Study:

  • To analyze and estimate the market size of global oral drug delivery market from 2016 to 2019.
  • To estimate and forecast the market size of global oral drug delivery market from 2020 to 2026 and growth rate until 2026.
  • To classify and forecast global oral drug delivery market based on formulation, type, therapy area, end user, company and regional distribution.
  • To identify dominant region or segment in the global oral drug delivery market.
  • To identify drivers and challenges for global oral drug delivery market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global oral drug delivery market.
  • To conduct pricing analysis for global oral drug delivery market.
  • To identify and analyze the profile of leading players operating in global oral drug delivery market.
  • To identify key sustainable strategies adopted by market players in global oral drug delivery market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the products and presence of all major players across the globe.

TechSci Research calculated the market size of global oral drug delivery market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

  • Oral drug delivery providing companies
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to oral drug delivery

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global oral drug delivery market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Oral Drug Delivery Market, By Formulation:
    • Tablets
    • Capsules
    • Drops
    • Liquid or Syrup
  • Global Oral Drug Delivery Market, By Type:
    • Controlled Release
    • Orodispersible Tablets
    • Others
  • Global Oral Drug Delivery Market, By Therapy Area:
    • Oncology
    • Musculoskeletal
    • Immunology
    • Gastrointestinal
    • Respiratory
    • Cardiovascular
    • Others
  • Global Oral Drug Delivery Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centres
    • Diagnostic Centres
    • Clinics
    • Others
  • Global Oral Drug Delivery Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global oral drug delivery market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global Oral Drug Delivery market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Oral Drug Delivery Market

4.    Executive Summary

5.    Voice of Customer

6.    Global Oral Drug Delivery Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Formulation (Tablets, Capsules, Drops, Liquid or Syrup)

6.2.2.     By Type (Controlled Release, Orodispersible Tablets, Others)

6.2.3.     By Therapy Area (Oncology, Musculoskeletal, Immunology, Gastrointestinal, Respiratory, Cardiovascular, Others)

6.2.4.     By End User (Hospitals, Ambulatory Surgical Centres, Diagnostic Centres, Clinics, Others)

6.2.5.     By Company

6.2.6.     By Region

6.3.  Product Market Map

7.    North America Continuous Oral Drug Delivery Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Formulation

7.2.2.     By Type

7.2.3.     By Therapy Area

7.2.4.     By End User

7.2.5.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Oral Drug Delivery Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Formulation

7.3.1.2.2.             By Type

7.3.1.2.3.             By Therapy Area

7.3.2.     Canada Oral Drug Delivery Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Formulation

7.3.2.2.2.             By Type

7.3.2.2.3.             By Therapy Area

7.3.3.     Mexico Oral Drug Delivery Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Formulation

7.3.3.2.2.             By Type

7.3.3.2.3.             By Therapy Area

8.    Europe Oral Drug Delivery Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Formulation

8.2.2.     By Type

8.2.3.     By Therapy Area

8.2.4.     By End User

8.2.5.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Oral Drug Delivery Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Formulation

8.3.1.2.2.             By Type

8.3.1.2.3.             By Therapy Area

8.3.2.     Germany Oral Drug Delivery Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Formulation

8.3.2.2.2.             By Type

8.3.2.2.3.             By Therapy Area

8.3.3.     United Kingdom Oral Drug Delivery Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Formulation

8.3.3.2.2.             By Type

8.3.3.2.3.             By Therapy Area

8.3.4.     Italy Oral Drug Delivery Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Formulation

8.3.4.2.2.             By Type

8.3.4.2.3.             By Therapy Area

8.3.5.     Spain Oral Drug Delivery Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Formulation

8.3.5.2.2.             By Type

8.3.5.2.3.             By Therapy Area

9.    Asia-Pacific Oral Drug Delivery Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Formulation

9.2.2.     By Type

9.2.3.     By Therapy Area

9.2.4.     By End User

9.2.5.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Oral Drug Delivery Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Formulation

9.3.1.2.2.             By Type

9.3.1.2.3.             By Therapy Area

9.3.2.     India Oral Drug Delivery Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Formulation

9.3.2.2.2.             By Type

9.3.2.2.3.             By Therapy Area

9.3.3.     Japan Oral Drug Delivery Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Formulation

9.3.3.2.2.             By Type

9.3.3.2.3.             By Therapy Area

9.3.4.     South Korea Oral Drug Delivery Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Formulation

9.3.4.2.2.             By Type

9.3.4.2.3.             By Therapy Area

9.3.5.     Australia Oral Drug Delivery Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Formulation

9.3.5.2.2.             By Type

9.3.5.2.3.             By Therapy Area

10.  Middle East and Africa Oral Drug Delivery Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Formulation

10.2.2.  By Type

10.2.3.  By Therapy Area

10.2.4.  By End User

10.2.5.  By Country

10.3.              MEA: Country Analysis

10.3.1.  South Africa Oral Drug Delivery Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Formulation

10.3.1.2.2.           By Type

10.3.1.2.3.           By Therapy Area

10.3.2.  Saudi Arabia Oral Drug Delivery Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Formulation

10.3.2.2.2.           By Type

10.3.2.2.3.           By Therapy Area

10.3.3.  UAE Oral Drug Delivery Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Formulation

10.3.3.2.2.           By Type

10.3.3.2.3.           By Therapy Area

11.  South America Oral Drug Delivery Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Formulation

11.2.2.  By Type

11.2.3.  By Therapy Area

11.2.4.  By End User

11.2.5.  By Country

11.3.              South America: Country Analysis

11.3.1.  Brazil Oral Drug Delivery Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Formulation

11.3.1.2.2.           By Type

11.3.1.2.3.           By Therapy Area

11.3.2.  Argentina Oral Drug Delivery Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Formulation

11.3.2.2.2.           By Type

11.3.2.2.3.           By Therapy Area

11.3.3.  Colombia Oral Drug Delivery Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Formulation

11.3.3.2.2.           By Type

11.3.3.2.3.           By Therapy Area

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Competition Outlook

14.2.              Company Profiles

14.2.1.  Novartis AG

14.2.2.  Biocon Ltd.

14.2.3.  NovoNordisk A/S

14.2.4.  F.Hoffmann-La Roche Ltd.

14.2.5.  Bayer AG

14.2.6.  Emishphere Technologies Inc.

14.2.7.  Enteris Biopharma Inc.

14.2.8.  Merrion Pharmaceuticals Plc.

14.2.9.  Amgen Inc.

14.2.10.                Pfizer Inc.

15.  Strategic Recommendations

16.  About Us & Disclaimer

                                                                                              (Note: The companies list can be customized based on the client requirements.)

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com